[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Polynovo Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Polynovo Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cambrex Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cambrex Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Can-Fite BioPharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Can-Fite BioPharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CanBas Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CanBas Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cangene Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cangene Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cannabis Science, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cannabis Science, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Canopus BioPharma Incorporated Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Canopus BioPharma Incorporated Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Caplin Point Laboratories Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caplin Point Laboratories Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Caps Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caps Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 34 pages

Capsalus Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capsalus Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Capstone Therapeutics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capstone Therapeutics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Caraco Pharmaceutical Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caraco Pharmaceutical Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CardioGenics Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CardioGenics Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cardiome Pharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cardiome Pharma Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CardioVascular BioTherapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CardioVascular BioTherapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cardium Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cardium Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Carna Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Carna Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Catalyst Pharmaceutical Partners Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Catalyst Pharmaceutical Partners Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cavit Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cavit Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CBio Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CBio Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CCM Duopharma Biotech Berhad Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CCM Duopharma Biotech Berhad Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Ceapro Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ceapro Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CEL-SCI Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CEL-SCI Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Celera Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celera Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Celestial Biolabs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celestial Biolabs Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Celgene Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celgene Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cell Biotech Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cell Biotech Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cell Kinetics Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cell Kinetics Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cell Tech International Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cell Tech International Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cell Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cell Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cellceutix Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellceutix Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cellcyte Genetics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellcyte Genetics Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Celldex Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celldex Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cellectis Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellectis Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cellestis Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellestis Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cellmid Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellmid Limited Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

CellSeed Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CellSeed Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Celltrion, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celltrion, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 64 pages

Celsion Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celsion Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Center Laboratories, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Center Laboratories, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cephalon Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cephalon Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cepheid Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cepheid Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cerep SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cerep SA Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Champions Biotechnology, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Champions Biotechnology, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chang'an Information Industry (group) Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chang'an Information Industry (group) Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Changchun High & New Technology Industry (Group) Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Changchun High & New Technology Industry (Group) Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Changyu Medtech Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Changyu Medtech Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Charles River Laboratories International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Charles River Laboratories International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Cheil Bio Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cheil Bio Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Chelsea Therapeutics International Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chelsea Therapeutics International Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

March 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers